Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryota Masuzaki

Showing results (1-10 of 96) with videos related to

Pageof 10
Sort By:
Cancers|September 28, 2023
Liver Cancer: Improving Standard Diagnosis and TherapyRyota Masuzaki
Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology|September 13, 2008
Treatment of hepatocellular carcinomaRyota Masuzaki, Masao Omata
World Journal of Hepatology|April 3, 2025
Smartphone-based Stroop Test, EncephalApp: What is the optimal cutoff for diagnosing minimal hepatic encephalopathy?Ryota Masuzaki, Hirofumi Kogure
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 16, 2010
Does chemotherapy prevent HCV-related hepatocellular carcinoma? ProsRyota Masuzaki, Haruhiko Yoshida, Masao Omata
Oncology|July 10, 2010
Interferon reduces the risk of hepatocellular carcinoma in hepatitis C virus-related chronic hepatitis/liver cirrhosisRyota Masuzaki, Haruhiko Yoshida, Masao Omata
Hepatology International|May 6, 2016
NAFLD as a risk factor for HCC: new rules of engagement?Ryota Masuzaki, Seth J Karp, Masao Omata
Seminars in Oncology|August 1, 2012
New serum markers of hepatocellular carcinomaRyota Masuzaki, Seth J Karp, Masao Omata
Journal of Hepatology|July 2, 2011
Pitavastatin enhances antiviral efficacy of standard pegylated interferon plus ribavirin in patients with chronic hepatitis C: a prospective randomized pilot studyMasahiko Shimada, Shuhei Yoshida, Ryota Masuzaki, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|November 11, 2009
Staging systems: is there a surgical staging and a medical one?: hepatologist's perspectiveRyota Masuzaki, Haruhiko Yoshida, Ryosuke Tateishi, et al.
Best Practice & Research. Clinical Gastroenterology|February 4, 2009
Hepatocellular carcinoma in viral hepatitis: improving standard therapyRyota Masuzaki, Haruhiko Yoshida, Ryosuke Tateishi, et al.
Pageof 10

Showing results (1-10 of 96) with videos related to

Sort By:
Pageof 10
Cancers|September 28, 2023
Liver Cancer: Improving Standard Diagnosis and TherapyRyota Masuzaki
Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology|September 13, 2008
Treatment of hepatocellular carcinomaRyota Masuzaki, Masao Omata
World Journal of Hepatology|April 3, 2025
Smartphone-based Stroop Test, EncephalApp: What is the optimal cutoff for diagnosing minimal hepatic encephalopathy?Ryota Masuzaki, Hirofumi Kogure
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 16, 2010
Does chemotherapy prevent HCV-related hepatocellular carcinoma? ProsRyota Masuzaki, Haruhiko Yoshida, Masao Omata
Oncology|July 10, 2010
Interferon reduces the risk of hepatocellular carcinoma in hepatitis C virus-related chronic hepatitis/liver cirrhosisRyota Masuzaki, Haruhiko Yoshida, Masao Omata
Hepatology International|May 6, 2016
NAFLD as a risk factor for HCC: new rules of engagement?Ryota Masuzaki, Seth J Karp, Masao Omata
Seminars in Oncology|August 1, 2012
New serum markers of hepatocellular carcinomaRyota Masuzaki, Seth J Karp, Masao Omata
Journal of Hepatology|July 2, 2011
Pitavastatin enhances antiviral efficacy of standard pegylated interferon plus ribavirin in patients with chronic hepatitis C: a prospective randomized pilot studyMasahiko Shimada, Shuhei Yoshida, Ryota Masuzaki, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|November 11, 2009
Staging systems: is there a surgical staging and a medical one?: hepatologist's perspectiveRyota Masuzaki, Haruhiko Yoshida, Ryosuke Tateishi, et al.
Best Practice & Research. Clinical Gastroenterology|February 4, 2009
Hepatocellular carcinoma in viral hepatitis: improving standard therapyRyota Masuzaki, Haruhiko Yoshida, Ryosuke Tateishi, et al.
Pageof 10